臨床口腔癌化特論(一)
Clinical Oral Oncology (1)
| 節 | 週五 |
|---|---|
8 16:30–17:20 | 臨床口腔癌化特論(一) YD302（陽明） 2 節連堂 |
9 17:30–18:20 |
* 根據陽明交大上課時間表所列
教師未提供此項資料
教師未提供此項資料
無備註
教師未提供此項資料
教師未提供此項資料
教師未提供此項資料
| 週次 | 主題 |
|---|---|
| 第 1 週 | p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer 2019/09/13 |
| 第 2 週 | Aging-like Spontaneous Epigenetic Silencing V600E Facilitates Wnt Activation, Stemness, and Braf Induced Tumorigenesis 2019/09/20 |
| 第 3 週 | Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism 2019/09/27 |
| 第 4 週 | NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma 2019/10/04 |
| 第 5 週 | KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer 2019/10/11 |
| 第 6 週 | Perturbation of mitochondrial bioenergetics by polycations counteracts resistance to BRAFE600 inhibition in melanoma cells 2019/10/18 |
| 第 7 週 | Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy 2019/10/25 |
| 第 8 週 | Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy 2019/11/01 |
| 第 9 週 | Introduction to Immune therapy 2019/11/08 |
| 第 10 週 | Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer 2019/11/15 |
| 第 11 週 | Tumor-intrinsic PIK3CA represses tumor immunogenicity in a model of pancreatic cancer 2019/11/22 |
| 第 12 週 | CRISPER in Oral Cancer Research 2019/11/29 |
| 第 13 週 | Cancer Database 2019/12/06 |
| 第 14 週 | Oral presentation-1 2019/12/13 |
| 第 15 週 | Oral presentation-2 2019/12/20 |
| 第 16 週 | Oral presentation-3 2019/12/27 |
| 第 17 週 | Oral presentation-4 2020/01/03 |
| 第 18 週 | Final report 2020/01/10 |
教師未提供此項資料
- 地點
- 教師未提供此項資料
- 時間
- 教師未提供此項資料
- 聯絡方式
- 教師未提供此項資料